WE HELP YOU KEEP YOUR FEET

VOTIS. A revolutionary new tool to safely screen, stage, and monitor the diabetic foot.

WE HELP YOU KEEP YOUR FEET

VOTIS is seeking investigators to lead clinical trials of our medical device for PAD diagnosis.

Would you like to participate as an investigator in our clinical trials?

VOTIS is a revolutionary new tool to safely screen, stage, and monitor the diabetic foot.

Z

VOTIS provides a clinical decision support for diagnosis and monitoring of diabetic foot syndrome and related conditions.

Z

VOTIS is designed for safe and repeated use over time, and for acute use during surgical procedures.

Z

VOTIS provides objective, repeatable, and measurable data useful to the doctor — regardless of treatment options being used.

Z

VOTIS is non-invasive and ionizing-radiation-free.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 876589.
Diabetic foot

Need

Chronic limb-threatening ischemia (CLTI) is an end-stage condition of peripheral artery disease (PAD), which hinders blood flow in the arteries of the leg.

Z

PAD affects more than 200 MILLION PEOPLE worldwide.

Z

CLTI affects 20 MILLION PEOPLE worldwide, 5 MILLION in the US and Europe.

Z

75 THOUSAND non-major amputations (about 2/3 of all amputations) are performed each year in the US.

Solution

VOTIS accompanies the PAD/CLTI patient throughout the patient journey.

P e d C h e c k T

The patient’s feet are screened for Peripheral Artery Disease.

Most likely, the patient is diabetic and 50 years old or older, or is younger but has had active diabetes for 10 years, or is younger and smokes.

P e d S t a g e T M

The patient’s specialists assess blood flow, oxygen flow in the foot, severity of ulcers or gangrene, and infection.

The health of the patient’s foot is assessed regularly for clinical decision support as various treatment options are applied.

P e d F l o T M

The doctor performing revascularization, bypass, open surgery, or minor or partial amputation uses the PedFlo™ to assess blood flow in the foot in real time.

For the first time, doctors can properly see what they are doing:.

P e d S t a g e ™ shows precise location and severity of disease.

An angiosome is an anatomical unit of tissue fed by a source artery and drained by specific veins.

The foot is divided into multiple angiosomes.

By identifying which areas of the foot lack perfusion, the doctor can identify occluded arteries in the leg.

P e d F l o ™ highlights significant changes to blood flow in real time.

Pedflo
Sudden change in hemoglobin in foot at injection of contrast dye into femoral artery at groin.

Portable, inexpensive, easy-to-use

Z

Votis is an inexpensive portable device

Z

Single-use consumable patches affixed to foot encase reusable laser diodes and photodetector sensors that automatically measure scattering and absorption of the light.

Z
Patches connect to small, lightweight unit that transmits information digitally via the cloud.
Z

Data is automatically converted into 3-digit (0-3) Wound, Ischemia, Foot-Infection (WIFI) Scale score.

Votis-machine

Technology

Solid IP position

Protects VOTIS technology and creates competitive barrier to entry.

Z

Seven issued US patents licensed from Columbia University cover hardware, software and cloud-based AI.

Z

License includes proprietary devices and processes developed in the lab and in the field during studies of human subjects.

Viable development plan to bring screening, staging, and intraoperative devices to market.

Team

Merrill Weber, JD

Merrill Weber, JD

Co-Founder, CEO & President

Previously, president of vascular medical device company sold for >$100 million.

Andreas H. Hielscher, PhD

Andreas H. Hielscher, PhD

Co-Founder & Chief Technology Advisor

Professor of Biophotonics, Columbia University.

Device inventor.

Prof. Brian Glenville, MD

Prof. Brian Glenville, MD

Executive Chairman

Cardiothoracic surgeon, Jerusalem and London, advisor to start-ups and investors.

Bezlel  Jacobowitz

Bezlel Jacobowitz

Chief Financial Officer

Accountant with more than 30 years of international operational and business development experience.
Karen De Hiep

Karen De Hiep

Marketing Director

, Former Director, Business Development, Philips New Wellness Solutions, Former Global Marketing Head Geriatrics, GI, Diabetes, Devices, Novartis/Nestle Medical Nutrition
Hamutal Shahar, PhD

Hamutal Shahar, PhD

Director of Clinical Affairs

Experienced with scientific and operational management of worldwide clinical trials. Extensive background in medical device, medical technology and drug studies.
Ephraim Siegel

Ephraim Siegel

MS Software Architect

Software designer and developer with 40 years’ experience.
Steve Epstein

Steve Epstein

MSEE

Cisco Systems Expert in Cloud computing, AI and Large Data Transfer Architecture.

David G. Armstrong

David G. Armstrong

DPM, MD, PhD

Leading global expert in amputation prevention and diabetic foot. Professor, USC.

Danielle Bajakian

Danielle Bajakian

MD, FACC

Surgical medical advisor; vascular surgeon and Director, Critical Limb Ischemia Program at Columbia University.

Roberto Ferraresi

Roberto Ferraresi

MD

Interventional cardiologist. Pioneer in lower limb interventions, particularly in patients with Critical Limb Ischemia, and a worldwide expert in diabetic foot revascularization. Performs more than 600 lower limb interventions per year.
Tomas Serena

Tomas Serena

Founder and CEO of The Serena Group, which runs wound-care centers throughout the US and internationally. Lead or principal investigator in more than 100 clinical trials. Past President, Association for the Advancement of Wound Care. Member, Council, European Wound Management Association.

 SCIENTIFIC ADVISORY BOARD

 

DAVID ARMSTRONG

DANIELLE BAJAKIAN

ROBERTO FERRARESI

BRIAN GLENVILLE

ANDREAS HIELSCHER

 

 BOARD OF DIRECTORS

 

BRIAN GLENVILLE (Executive Chairman)

EDWARD KAPLAN

JERRY KOKOSHKA (Observer)

YARON SUISSA

MERRILL WEBER

CLAUDIO ZUCCOLOTTO

 

News

November 2021

Interview with CEO Merrill Weber for Diabetes Awareness Month on i24 News

June 2021

Votis Subdermal Imaging Technologies Raises US$2.5 Million

December 2020

VOTIS Subdermal Imaging Technologies And ii Ventures Announce Plans To Develop Preventative Medicine Devices To Screen For Peripheral Artery Disease In India

August 2020

Helping diabetics keep their feet

August 2020

Diabetic foot ulcer management in a multidisciplinary foot centre: one-year healing, amputation and mortality rate

Contact